)
Visual
test
Zenas BioPharma
Zenas BioPharma (ZBIO) investor relations material
Zenas BioPharma Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy Filing summary16 Mar, 2026
Voting matters and shareholder proposals
Election of two Class II director nominees, James Boylan and Patrick Enright, to serve until the 2029 Annual Meeting and until successors are elected and qualified.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2026.
Provision to transact any other matters that may properly come before the Annual Meeting or any adjournments or postponements.
Board of directors and corporate governance
Board recommends voting in favor of both director nominees and the auditor ratification.
Audit committee and external auditor matters
Proposal to ratify Ernst & Young LLP as the external auditor for the upcoming fiscal year.
Class II director term expiration
Ratification of the 2026 independent auditor
Handling of additional meeting business
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Zenas BioPharma
- 2026 meeting to elect directors, ratify auditor, and highlight governance, compensation, and ESG.ZBIO
Proxy Filing16 Mar 2026 - Late-stage pipeline and global launch readiness drive multi-billion dollar autoimmune market entry.ZBIOCorporate presentation16 Mar 2026
- Strong clinical progress and financing position offset by increased net loss in 2025.ZBIOQ4 202516 Mar 2026
- Obexelimab shows strong efficacy, safety, and commercial promise in IgG4-RD and beyond.ZBIOGuggenheim Securities Emerging Outlook: Biotech Summit 202611 Feb 2026
- Obexelimab's global trials target major autoimmune markets with key data expected by late 2025.ZBIOJefferies London Healthcare Conference 202413 Jan 2026
- Obexelimab advances in late-stage autoimmune trials, offering rapid, convenient B-cell inhibition.ZBIOCiti's 2024 Global Healthcare Conference12 Jan 2026
- Advancing late-stage autoimmune and MS therapies with major milestones and market potential.ZBIOCorporate Presentation5 Jan 2026
- Obexelimab cut IgG4-RD flare risk by 56% in Phase 3, meeting all endpoints with strong safety.ZBIOStudy Result5 Jan 2026
- Obexelimab's pivotal trials in MS, IgG4-RD, and SLE target major 2024–2025 milestones.ZBIOGuggenheim SMID Cap Biotech Conference23 Dec 2025
Next Zenas BioPharma earnings date
Q1 202615 May, 2026
Zenas BioPharma
Next Zenas BioPharma earnings date
Q1 202615 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage